N/A
N=116
Text-Message-Based Depression Prevention for High-Risk Youth in the ED
Depressive Disorder · Violence
Bottom Line
View on ClinicalTrials.gov: NCT02332239 ↗Enrolled (actual)
116
Serious AEs
0.0%
Results posted
Dec 2017
Primary outcome: Primary: Change in Depressive Symptoms — 13.6; 13.4; 14.8; 15.0 units on a scale — p=0.07
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- iDOVE Intervention (ED+text) (Behavioral); Control (EUC) (Behavioral)
- Age
- Pediatric · 13+ yrs
- Sex
- All
- Sponsor
- Rhode Island Hospital
- Primary completion
- Feb 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Depressive Symptoms |
13.6; 13.4; 14.8; 15.0; 12.5; 11.7 | 0.07 |
| PRIMARY Change in Peer Violence Involvement |
3.0; 2.0; 2.5; 3.0; 2.0; 1.0 | 0.01 sig |
| SECONDARY Acceptability/Feasibility: Follow Up Rate |
55; 55; 54; 52 | — |
| SECONDARY Acceptability/Feasibility: Engagement of Intervention Group |
56; 22 | — |
| SECONDARY Acceptability/Feasibility: Participant Satisfaction |
32.3; 31.2 | 0.33 |
Summary
The purpose of this randomized controlled study is to evaluate acceptability and feasibility, and to gather preliminary data about efficacy, of "iDOVE," a brief emergency department introductory session + longitudinal automated text-message depression prevention program for high-risk teens.
Eligibility Criteria
Inclusion Criteria
- English-speaking
- presenting to the emergency department for routine care
- reporting past-year physical violence (using a modified version of The Revised Conflict Tactics Scales (CTS)) and current mild-to-moderate depressive symptoms (using Patient Health Questionnaire (PHQ)-9), as identified on a brief screen administered in the ED
- accompanied by a consentable parent
- own or have access to a text-message-capable mobile phone
Exclusion Criteria
- medically/physically unable to assent
- chief complaint of suicidal ideation, psychosis, or child abuse
- in police custody
- severe depressive symptoms
Data sourced from ClinicalTrials.gov (NCT02332239). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.